Abiopharma

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206599 <b>Size:</b> 775 KB

New Form DEF 14A - Range Capital Acquisition Corp. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206596 <b>Size:</b> 895 KB

New Form 3 - Pasithea Therapeutics Corp. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001213900-26-052254 <b>Size:</b> 3 KB

New Form SCHEDULE 13D/A - MFS HIGH YIELD MUNICIPAL TRUST <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001398344-26-008398 <b>Size:</b> 10 KB

Director Babcock Beverley A 🟢 acquired 7.0K shares (1 derivative) of OLIN Corp (OLN) at $28.48 Transaction Date: May 01, 2026 | Filing ID: 000002

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206593 <b>Size:</b> 416 KB

Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026

TCOM 6-DAY DEADLINE ALERT: Trip.com (TCOM) Facing Securities Class Action After AI Pricing Controversy and Anti-Monopoly Probe Sends Shares Tumbling -- Hagens Berman

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001839882-26-023072 <b>Size:</b> 375 KB

New Form SCHEDULE 13G/A - MFS HIGH YIELD MUNICIPAL TRUST <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206592 <b>Size:</b> 8 KB

EquipmentShare Announces First Quarter 2026 Financial Results Conference Call

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206588 <b>Size:</b> 632 KB

New Form DEFA14A - Salesforce, Inc. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001108524-26-000093 <b>Size:</b> 2 MB

New Form SCHEDULE 13G/A - NEUBERGER REAL ESTATE SECURITIES INCOME FUND INC <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0000897101-26-000156 <b>Size:</b> 10 KB

New Form DEFA14A - First Seacoast Bancorp, Inc. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206585 <b>Size:</b> 26 KB